Effects of Candesartan to Left Ventricular Mass in Treatment for Primary Hypertension with Left Ventricular Hypertrophy
Cao Guang-f
Abstract
Cao Guang-f
Abstract
Objective:To evaluate the role of AngⅡ receptor blocker in treatment to primary hypertension with left ventricular hypertrophy and its effects to myocardial mass,so as to indicate the anti-myocardial hypertrophy effect of this medicine.Methods:Fifty patients diagnosed primary hypertension with left ventricular hypertrophy were enrolled.They had been asked to take Candesartan 4-8mg/d,for 3 months.Results:Patients' BP,IVST,LVPWT,LVDd,LVMI were significantly lowered after 3 months' treatment with Candesartan.Conclusion:Candesartan could ameliorate the left ventricular hypertrophy caused by primary hypertension in a relatively short term.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To evaluate the role of AngⅡ receptor blocker in treatment to primary hypertension with left ventricular hypertrophy and its effects to myocardial mass,so as to indicate the anti-myocardial hypertrophy effect of this medicine.Methods:Fifty patients diagnosed primary hypertension with left ventricular hypertrophy were enrolled.They had been asked to take Candesartan 4-8mg/d,for 3 months.Results:Patients' BP,IVST,LVPWT,LVDd,LVMI were significantly lowered after 3 months' treatment with Candesartan.Conclusion:Candesartan could ameliorate the left ventricular hypertrophy caused by primary hypertension in a relatively short term.
Key concepts: Candesartan, Medicine, Left ventricular hypertrophy, Cardiology, Internal medicine, Muscle hypertrophy, Blood pressure, Angiotensin II